nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—brain cancer	0.699	1	CbGaD
Fulvestrant—CYP3A4—Temozolomide—brain cancer	0.0357	0.487	CbGbCtD
Fulvestrant—CYP3A4—Lomustine—brain cancer	0.0304	0.414	CbGbCtD
Fulvestrant—EPHX2—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0166	0.197	CbGpPWpGaD
Fulvestrant—EPHX2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0149	0.177	CbGpPWpGaD
Fulvestrant—NR1H4—skull—brain cancer	0.0128	0.26	CbGeAlD
Fulvestrant—CYP3A4—Etoposide—brain cancer	0.00734	0.1	CbGbCtD
Fulvestrant—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—brain cancer	0.0042	0.0498	CbGpPWpGaD
Fulvestrant—EPHX2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00345	0.0408	CbGpPWpGaD
Fulvestrant—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00274	0.0325	CbGpPWpGaD
Fulvestrant—ESR2—hindbrain—brain cancer	0.00232	0.0471	CbGeAlD
Fulvestrant—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.0019	0.0208	CcSEcCtD
Fulvestrant—EPHX2—pituitary gland—brain cancer	0.00183	0.0371	CbGeAlD
Fulvestrant—NR1H4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00174	0.0206	CbGpPWpGaD
Fulvestrant—Digestion impaired—Hydroxyurea—brain cancer	0.00167	0.0183	CcSEcCtD
Fulvestrant—ESR1—blood vessel—brain cancer	0.00167	0.0338	CbGeAlD
Fulvestrant—NR1H4—endocrine gland—brain cancer	0.00162	0.0329	CbGeAlD
Fulvestrant—ESRRA—pituitary gland—brain cancer	0.0016	0.0325	CbGeAlD
Fulvestrant—ESR1—hindbrain—brain cancer	0.00159	0.0323	CbGeAlD
Fulvestrant—ESRRA—Nuclear Receptors—ESR2—brain cancer	0.00159	0.0188	CbGpPWpGaD
Fulvestrant—ESRRA—medulla oblongata—brain cancer	0.00155	0.0314	CbGeAlD
Fulvestrant—Estradiol—ESR2—brain cancer	0.00147	0.56	CrCbGaD
Fulvestrant—ESRRA—midbrain—brain cancer	0.00141	0.0287	CbGeAlD
Fulvestrant—NR1H4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00141	0.0167	CbGpPWpGaD
Fulvestrant—ESRRA—spinal cord—brain cancer	0.00138	0.028	CbGeAlD
Fulvestrant—NR1H4—Orphan transporters—S100A10—brain cancer	0.00135	0.016	CbGpPWpGaD
Fulvestrant—ESR2—brainstem—brain cancer	0.00133	0.027	CbGeAlD
Fulvestrant—NR1H4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00131	0.0155	CbGpPWpGaD
Fulvestrant—Digestion impaired—Temozolomide—brain cancer	0.0013	0.0143	CcSEcCtD
Fulvestrant—EPHX2—Metapathway biotransformation—CYP2C9—brain cancer	0.00126	0.015	CbGpPWpGaD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00125	0.0149	CbGpPWpGaD
Fulvestrant—EPHX2—cerebellum—brain cancer	0.00125	0.0253	CbGeAlD
Fulvestrant—ESRRA—endocrine gland—brain cancer	0.00124	0.0252	CbGeAlD
Fulvestrant—ESRRA—head—brain cancer	0.00122	0.0249	CbGeAlD
Fulvestrant—ESR2—telencephalon—brain cancer	0.00118	0.024	CbGeAlD
Fulvestrant—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00118	0.0129	CcSEcCtD
Fulvestrant—Vaginal haemorrhage—Temozolomide—brain cancer	0.00118	0.0129	CcSEcCtD
Fulvestrant—Estradiol—CYP2C9—brain cancer	0.00115	0.44	CrCbGaD
Fulvestrant—Haemoglobin—Lomustine—brain cancer	0.00115	0.0125	CcSEcCtD
Fulvestrant—Haemorrhage—Lomustine—brain cancer	0.00114	0.0125	CcSEcCtD
Fulvestrant—ESRRA—central nervous system—brain cancer	0.00112	0.0227	CbGeAlD
Fulvestrant—Injection site pain—Carmustine—brain cancer	0.0011	0.0121	CcSEcCtD
Fulvestrant—ESRRA—cerebellum—brain cancer	0.00109	0.0222	CbGeAlD
Fulvestrant—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00106	0.0116	CcSEcCtD
Fulvestrant—ESR1—LKB1 signaling events—STRADA—brain cancer	0.00105	0.0125	CbGpPWpGaD
Fulvestrant—Accidental injury—Carmustine—brain cancer	0.00102	0.0112	CcSEcCtD
Fulvestrant—EPHX2—brain—brain cancer	0.00101	0.0206	CbGeAlD
Fulvestrant—ESR2—gonad—brain cancer	0.000985	0.02	CbGeAlD
Fulvestrant—ESR2—pituitary gland—brain cancer	0.000961	0.0195	CbGeAlD
Fulvestrant—Hepatic enzyme increased—Temozolomide—brain cancer	0.000921	0.0101	CcSEcCtD
Fulvestrant—Infection—Carboplatin—brain cancer	0.000919	0.0101	CcSEcCtD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000916	0.0109	CbGpPWpGaD
Fulvestrant—ESR1—brainstem—brain cancer	0.000911	0.0185	CbGeAlD
Fulvestrant—Hepatic failure—Hydroxyurea—brain cancer	0.000901	0.00987	CcSEcCtD
Fulvestrant—Injection site reaction—Carmustine—brain cancer	0.000896	0.00982	CcSEcCtD
Fulvestrant—Leukopenia—Lomustine—brain cancer	0.000888	0.00973	CcSEcCtD
Fulvestrant—ESRRA—brain—brain cancer	0.000888	0.018	CbGeAlD
Fulvestrant—Musculoskeletal pain—Temozolomide—brain cancer	0.000882	0.00966	CcSEcCtD
Fulvestrant—ESR1—telencephalon—brain cancer	0.000809	0.0164	CbGeAlD
Fulvestrant—Infection—Lomustine—brain cancer	0.000804	0.00881	CcSEcCtD
Fulvestrant—Pain—Carboplatin—brain cancer	0.000791	0.00867	CcSEcCtD
Fulvestrant—ESR1—Nuclear signaling by ERBB4—GFAP—brain cancer	0.000788	0.00934	CbGpPWpGaD
Fulvestrant—Sweating—Procarbazine—brain cancer	0.000773	0.00847	CcSEcCtD
Fulvestrant—Anorexia—Lomustine—brain cancer	0.000772	0.00846	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—HES5—brain cancer	0.000767	0.00908	CbGpPWpGaD
Fulvestrant—NR1H4—Biological oxidations—CYP2C9—brain cancer	0.000749	0.00888	CbGpPWpGaD
Fulvestrant—ESR2—endocrine gland—brain cancer	0.000745	0.0151	CbGeAlD
Fulvestrant—ESR2—head—brain cancer	0.000735	0.0149	CbGeAlD
Fulvestrant—Body temperature increased—Carboplatin—brain cancer	0.000732	0.00802	CcSEcCtD
Fulvestrant—Breast disorder—Hydroxyurea—brain cancer	0.000731	0.00801	CcSEcCtD
Fulvestrant—Haemoglobin—Procarbazine—brain cancer	0.000727	0.00797	CcSEcCtD
Fulvestrant—Haemorrhage—Procarbazine—brain cancer	0.000723	0.00793	CcSEcCtD
Fulvestrant—Inflammation—Etoposide—brain cancer	0.000719	0.00787	CcSEcCtD
Fulvestrant—Injury—Carmustine—brain cancer	0.000712	0.0078	CcSEcCtD
Fulvestrant—ESR2—Ovarian Infertility Genes—CDK4—brain cancer	0.000706	0.00836	CbGpPWpGaD
Fulvestrant—Decreased appetite—Lomustine—brain cancer	0.000704	0.00771	CcSEcCtD
Fulvestrant—Hepatic failure—Temozolomide—brain cancer	0.000704	0.00771	CcSEcCtD
Fulvestrant—Hot flush—Temozolomide—brain cancer	0.000676	0.00741	CcSEcCtD
Fulvestrant—ESR1—gonad—brain cancer	0.000675	0.0137	CbGeAlD
Fulvestrant—ESR2—central nervous system—brain cancer	0.000671	0.0136	CbGeAlD
Fulvestrant—Menopausal symptoms—Temozolomide—brain cancer	0.00067	0.00734	CcSEcCtD
Fulvestrant—ESR1—pituitary gland—brain cancer	0.000658	0.0134	CbGeAlD
Fulvestrant—ESR2—cerebellum—brain cancer	0.000656	0.0133	CbGeAlD
Fulvestrant—Body temperature increased—Lomustine—brain cancer	0.00064	0.00701	CcSEcCtD
Fulvestrant—Infestation—Hydroxyurea—brain cancer	0.000624	0.00683	CcSEcCtD
Fulvestrant—Infestation NOS—Hydroxyurea—brain cancer	0.000624	0.00683	CcSEcCtD
Fulvestrant—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.0006	0.00711	CbGpPWpGaD
Fulvestrant—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00059	0.00646	CcSEcCtD
Fulvestrant—Anaemia—Procarbazine—brain cancer	0.000582	0.00638	CcSEcCtD
Fulvestrant—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000577	0.00683	CbGpPWpGaD
Fulvestrant—Breast disorder—Temozolomide—brain cancer	0.000571	0.00626	CcSEcCtD
Fulvestrant—ESR1—FOXA1 transcription factor network—SHH—brain cancer	0.000566	0.00671	CbGpPWpGaD
Fulvestrant—Leukopenia—Procarbazine—brain cancer	0.000564	0.00618	CcSEcCtD
Fulvestrant—Haemoglobin—Hydroxyurea—brain cancer	0.000563	0.00617	CcSEcCtD
Fulvestrant—Haemorrhage—Hydroxyurea—brain cancer	0.00056	0.00614	CcSEcCtD
Fulvestrant—ESR1—FOXM1 transcription factor network—SKP2—brain cancer	0.000557	0.0066	CbGpPWpGaD
Fulvestrant—Cough—Procarbazine—brain cancer	0.00055	0.00602	CcSEcCtD
Fulvestrant—Myalgia—Procarbazine—brain cancer	0.000536	0.00588	CcSEcCtD
Fulvestrant—Arthralgia—Procarbazine—brain cancer	0.000536	0.00588	CcSEcCtD
Fulvestrant—Anxiety—Procarbazine—brain cancer	0.000534	0.00585	CcSEcCtD
Fulvestrant—ESR2—brain—brain cancer	0.000533	0.0108	CbGeAlD
Fulvestrant—Vomiting—Lomustine—brain cancer	0.000515	0.00564	CcSEcCtD
Fulvestrant—Infection—Procarbazine—brain cancer	0.000511	0.0056	CcSEcCtD
Fulvestrant—ESR1—endocrine gland—brain cancer	0.00051	0.0104	CbGeAlD
Fulvestrant—ESR1—Nuclear Receptors—ESR2—brain cancer	0.000509	0.00603	CbGpPWpGaD
Fulvestrant—Angiopathy—Hydroxyurea—brain cancer	0.000508	0.00557	CcSEcCtD
Fulvestrant—ESR1—head—brain cancer	0.000503	0.0102	CbGeAlD
Fulvestrant—Depression—Carmustine—brain cancer	0.000503	0.00551	CcSEcCtD
Fulvestrant—Hyperhidrosis—Procarbazine—brain cancer	0.000497	0.00544	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000492	0.00584	CbGpPWpGaD
Fulvestrant—Urinary tract infection—Carmustine—brain cancer	0.00049	0.00537	CcSEcCtD
Fulvestrant—Anorexia—Procarbazine—brain cancer	0.00049	0.00537	CcSEcCtD
Fulvestrant—Infestation NOS—Temozolomide—brain cancer	0.000487	0.00534	CcSEcCtD
Fulvestrant—Infestation—Temozolomide—brain cancer	0.000487	0.00534	CcSEcCtD
Fulvestrant—Depression—Temozolomide—brain cancer	0.000486	0.00532	CcSEcCtD
Fulvestrant—Nausea—Lomustine—brain cancer	0.000481	0.00527	CcSEcCtD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—ESR2—brain cancer	0.000479	0.00568	CbGpPWpGaD
Fulvestrant—Urinary tract infection—Temozolomide—brain cancer	0.000474	0.00519	CcSEcCtD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000469	0.00556	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000468	0.00513	CcSEcCtD
Fulvestrant—Insomnia—Procarbazine—brain cancer	0.000465	0.00509	CcSEcCtD
Fulvestrant—Paraesthesia—Procarbazine—brain cancer	0.000462	0.00506	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Temozolomide—brain cancer	0.000461	0.00505	CcSEcCtD
Fulvestrant—ESR1—central nervous system—brain cancer	0.00046	0.00933	CbGeAlD
Fulvestrant—Haemoglobin—Carmustine—brain cancer	0.000455	0.00498	CcSEcCtD
Fulvestrant—Haemorrhage—Carmustine—brain cancer	0.000453	0.00496	CcSEcCtD
Fulvestrant—Anaemia—Hydroxyurea—brain cancer	0.000451	0.00494	CcSEcCtD
Fulvestrant—ESR1—cerebellum—brain cancer	0.000449	0.00912	CbGeAlD
Fulvestrant—Decreased appetite—Procarbazine—brain cancer	0.000447	0.0049	CcSEcCtD
Fulvestrant—Oedema peripheral—Carmustine—brain cancer	0.000446	0.00489	CcSEcCtD
Fulvestrant—Connective tissue disorder—Carmustine—brain cancer	0.000445	0.00487	CcSEcCtD
Fulvestrant—Fatigue—Procarbazine—brain cancer	0.000443	0.00486	CcSEcCtD
Fulvestrant—Haemoglobin—Temozolomide—brain cancer	0.00044	0.00482	CcSEcCtD
Fulvestrant—Pain—Procarbazine—brain cancer	0.00044	0.00482	CcSEcCtD
Fulvestrant—Constipation—Procarbazine—brain cancer	0.00044	0.00482	CcSEcCtD
Fulvestrant—Haemorrhage—Temozolomide—brain cancer	0.000437	0.00479	CcSEcCtD
Fulvestrant—Hepatitis—Temozolomide—brain cancer	0.000437	0.00479	CcSEcCtD
Fulvestrant—Leukopenia—Hydroxyurea—brain cancer	0.000436	0.00478	CcSEcCtD
Fulvestrant—Pharyngitis—Temozolomide—brain cancer	0.000434	0.00476	CcSEcCtD
Fulvestrant—Oedema peripheral—Temozolomide—brain cancer	0.000431	0.00472	CcSEcCtD
Fulvestrant—Connective tissue disorder—Temozolomide—brain cancer	0.00043	0.00471	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Procarbazine—brain cancer	0.00042	0.00461	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000412	0.00452	CcSEcCtD
Fulvestrant—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000412	0.00488	CbGpPWpGaD
Fulvestrant—Urticaria—Procarbazine—brain cancer	0.000408	0.00447	CcSEcCtD
Fulvestrant—ESR1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000408	0.00483	CbGpPWpGaD
Fulvestrant—Abdominal pain—Procarbazine—brain cancer	0.000406	0.00445	CcSEcCtD
Fulvestrant—Body temperature increased—Procarbazine—brain cancer	0.000406	0.00445	CcSEcCtD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000402	0.00477	CbGpPWpGaD
Fulvestrant—Angiopathy—Temozolomide—brain cancer	0.000397	0.00435	CcSEcCtD
Fulvestrant—Infection—Hydroxyurea—brain cancer	0.000395	0.00433	CcSEcCtD
Fulvestrant—Immune system disorder—Temozolomide—brain cancer	0.000395	0.00433	CcSEcCtD
Fulvestrant—Malnutrition—Carmustine—brain cancer	0.000394	0.00432	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000394	0.00467	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000392	0.00465	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Hydroxyurea—brain cancer	0.00039	0.00427	CcSEcCtD
Fulvestrant—Infestation NOS—Etoposide—brain cancer	0.00039	0.00427	CcSEcCtD
Fulvestrant—Infestation—Etoposide—brain cancer	0.00039	0.00427	CcSEcCtD
Fulvestrant—Skin disorder—Hydroxyurea—brain cancer	0.000386	0.00423	CcSEcCtD
Fulvestrant—ESR1—FOXM1 transcription factor network—BRCA2—brain cancer	0.000386	0.00457	CbGpPWpGaD
Fulvestrant—Back pain—Carmustine—brain cancer	0.000381	0.00418	CcSEcCtD
Fulvestrant—Malnutrition—Temozolomide—brain cancer	0.000381	0.00417	CcSEcCtD
Fulvestrant—Anorexia—Hydroxyurea—brain cancer	0.000379	0.00415	CcSEcCtD
Fulvestrant—Hypersensitivity—Procarbazine—brain cancer	0.000379	0.00415	CcSEcCtD
Fulvestrant—ESR1—FOXM1 transcription factor network—CCNE1—brain cancer	0.000374	0.00443	CbGpPWpGaD
Fulvestrant—Asthenia—Procarbazine—brain cancer	0.000369	0.00404	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Etoposide—brain cancer	0.000369	0.00404	CcSEcCtD
Fulvestrant—Back pain—Temozolomide—brain cancer	0.000368	0.00404	CcSEcCtD
Fulvestrant—ESR1—brain—brain cancer	0.000365	0.00741	CbGeAlD
Fulvestrant—Anaemia—Carmustine—brain cancer	0.000364	0.00399	CcSEcCtD
Fulvestrant—Pruritus—Procarbazine—brain cancer	0.000364	0.00398	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00036	0.00427	CbGpPWpGaD
Fulvestrant—Dyspnoea—Hydroxyurea—brain cancer	0.000355	0.00389	CcSEcCtD
Fulvestrant—Leukopenia—Carmustine—brain cancer	0.000353	0.00386	CcSEcCtD
Fulvestrant—Anaemia—Temozolomide—brain cancer	0.000352	0.00386	CcSEcCtD
Fulvestrant—Diarrhoea—Procarbazine—brain cancer	0.000352	0.00385	CcSEcCtD
Fulvestrant—Dyspepsia—Hydroxyurea—brain cancer	0.00035	0.00384	CcSEcCtD
Fulvestrant—Angioedema—Temozolomide—brain cancer	0.000348	0.00381	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000347	0.00411	CbGpPWpGaD
Fulvestrant—Decreased appetite—Hydroxyurea—brain cancer	0.000346	0.00379	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000343	0.00376	CcSEcCtD
Fulvestrant—Fatigue—Hydroxyurea—brain cancer	0.000343	0.00376	CcSEcCtD
Fulvestrant—Vertigo—Temozolomide—brain cancer	0.000342	0.00375	CcSEcCtD
Fulvestrant—Leukopenia—Temozolomide—brain cancer	0.000341	0.00373	CcSEcCtD
Fulvestrant—Constipation—Hydroxyurea—brain cancer	0.00034	0.00373	CcSEcCtD
Fulvestrant—Pain—Hydroxyurea—brain cancer	0.00034	0.00373	CcSEcCtD
Fulvestrant—Dizziness—Procarbazine—brain cancer	0.00034	0.00372	CcSEcCtD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.000336	0.00398	CbGpPWpGaD
Fulvestrant—Chest pain—Carmustine—brain cancer	0.000335	0.00368	CcSEcCtD
Fulvestrant—Myalgia—Carmustine—brain cancer	0.000335	0.00368	CcSEcCtD
Fulvestrant—Anxiety—Carmustine—brain cancer	0.000334	0.00366	CcSEcCtD
Fulvestrant—Cough—Temozolomide—brain cancer	0.000332	0.00364	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—S100A10—brain cancer	0.00033	0.00391	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000329	0.0039	CbGpPWpGaD
Fulvestrant—Vomiting—Procarbazine—brain cancer	0.000327	0.00358	CcSEcCtD
Fulvestrant—Arthralgia—Temozolomide—brain cancer	0.000324	0.00355	CcSEcCtD
Fulvestrant—Myalgia—Temozolomide—brain cancer	0.000324	0.00355	CcSEcCtD
Fulvestrant—Rash—Procarbazine—brain cancer	0.000324	0.00355	CcSEcCtD
Fulvestrant—Dermatitis—Procarbazine—brain cancer	0.000324	0.00355	CcSEcCtD
Fulvestrant—Anxiety—Temozolomide—brain cancer	0.000323	0.00354	CcSEcCtD
Fulvestrant—Headache—Procarbazine—brain cancer	0.000322	0.00353	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000322	0.00353	CcSEcCtD
Fulvestrant—Infection—Carmustine—brain cancer	0.000319	0.0035	CcSEcCtD
Fulvestrant—Angiopathy—Etoposide—brain cancer	0.000318	0.00348	CcSEcCtD
Fulvestrant—Immune system disorder—Etoposide—brain cancer	0.000316	0.00346	CcSEcCtD
Fulvestrant—Body temperature increased—Hydroxyurea—brain cancer	0.000314	0.00345	CcSEcCtD
Fulvestrant—Infection—Temozolomide—brain cancer	0.000309	0.00338	CcSEcCtD
Fulvestrant—Anorexia—Carmustine—brain cancer	0.000307	0.00336	CcSEcCtD
Fulvestrant—Nausea—Procarbazine—brain cancer	0.000305	0.00335	CcSEcCtD
Fulvestrant—Nervous system disorder—Temozolomide—brain cancer	0.000305	0.00334	CcSEcCtD
Fulvestrant—Skin disorder—Temozolomide—brain cancer	0.000302	0.00331	CcSEcCtD
Fulvestrant—Hyperhidrosis—Temozolomide—brain cancer	0.0003	0.00329	CcSEcCtD
Fulvestrant—Anorexia—Temozolomide—brain cancer	0.000296	0.00325	CcSEcCtD
Fulvestrant—Back pain—Etoposide—brain cancer	0.000295	0.00323	CcSEcCtD
Fulvestrant—Hypersensitivity—Hydroxyurea—brain cancer	0.000293	0.00321	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Carmustine—brain cancer	0.000293	0.00321	CcSEcCtD
Fulvestrant—Insomnia—Carmustine—brain cancer	0.000291	0.00319	CcSEcCtD
Fulvestrant—Paraesthesia—Carmustine—brain cancer	0.000289	0.00316	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000288	0.00341	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000288	0.00341	CbGpPWpGaD
Fulvestrant—Dyspnoea—Carmustine—brain cancer	0.000287	0.00314	CcSEcCtD
Fulvestrant—ESR1—FOXM1 transcription factor network—CDK4—brain cancer	0.000286	0.00339	CbGpPWpGaD
Fulvestrant—Asthenia—Hydroxyurea—brain cancer	0.000285	0.00313	CcSEcCtD
Fulvestrant—CYP3A4—endocrine gland—brain cancer	0.000285	0.00578	CbGeAlD
Fulvestrant—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000283	0.0031	CcSEcCtD
Fulvestrant—Anaemia—Etoposide—brain cancer	0.000282	0.00309	CcSEcCtD
Fulvestrant—Insomnia—Temozolomide—brain cancer	0.000281	0.00308	CcSEcCtD
Fulvestrant—Decreased appetite—Carmustine—brain cancer	0.00028	0.00306	CcSEcCtD
Fulvestrant—Paraesthesia—Temozolomide—brain cancer	0.000279	0.00306	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—HES1—brain cancer	0.000278	0.0033	CbGpPWpGaD
Fulvestrant—Gastrointestinal disorder—Carmustine—brain cancer	0.000278	0.00304	CcSEcCtD
Fulvestrant—Dyspnoea—Temozolomide—brain cancer	0.000277	0.00304	CcSEcCtD
Fulvestrant—Pain—Carmustine—brain cancer	0.000275	0.00301	CcSEcCtD
Fulvestrant—Constipation—Carmustine—brain cancer	0.000275	0.00301	CcSEcCtD
Fulvestrant—Vertigo—Etoposide—brain cancer	0.000274	0.003	CcSEcCtD
Fulvestrant—Dyspepsia—Temozolomide—brain cancer	0.000274	0.003	CcSEcCtD
Fulvestrant—Leukopenia—Etoposide—brain cancer	0.000273	0.00299	CcSEcCtD
Fulvestrant—Diarrhoea—Hydroxyurea—brain cancer	0.000272	0.00298	CcSEcCtD
Fulvestrant—Decreased appetite—Temozolomide—brain cancer	0.00027	0.00296	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Temozolomide—brain cancer	0.000268	0.00294	CcSEcCtD
Fulvestrant—Fatigue—Temozolomide—brain cancer	0.000268	0.00294	CcSEcCtD
Fulvestrant—Cough—Etoposide—brain cancer	0.000266	0.00291	CcSEcCtD
Fulvestrant—Constipation—Temozolomide—brain cancer	0.000266	0.00291	CcSEcCtD
Fulvestrant—Pain—Temozolomide—brain cancer	0.000266	0.00291	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—GFAP—brain cancer	0.000266	0.00315	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—PDGFRA—brain cancer	0.000265	0.00314	CbGpPWpGaD
Fulvestrant—Dizziness—Hydroxyurea—brain cancer	0.000263	0.00288	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Carmustine—brain cancer	0.000263	0.00288	CcSEcCtD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000262	0.0031	CbGpPWpGaD
Fulvestrant—Chest pain—Etoposide—brain cancer	0.000259	0.00284	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000258	0.00282	CcSEcCtD
Fulvestrant—CYP3A4—central nervous system—brain cancer	0.000256	0.00521	CbGeAlD
Fulvestrant—Abdominal pain—Carmustine—brain cancer	0.000254	0.00279	CcSEcCtD
Fulvestrant—Body temperature increased—Carmustine—brain cancer	0.000254	0.00279	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Temozolomide—brain cancer	0.000254	0.00278	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000253	0.003	CbGpPWpGaD
Fulvestrant—Vomiting—Hydroxyurea—brain cancer	0.000253	0.00277	CcSEcCtD
Fulvestrant—Rash—Hydroxyurea—brain cancer	0.000251	0.00275	CcSEcCtD
Fulvestrant—Dermatitis—Hydroxyurea—brain cancer	0.000251	0.00275	CcSEcCtD
Fulvestrant—Headache—Hydroxyurea—brain cancer	0.000249	0.00273	CcSEcCtD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000249	0.00295	CbGpPWpGaD
Fulvestrant—Infection—Etoposide—brain cancer	0.000247	0.00271	CcSEcCtD
Fulvestrant—Urticaria—Temozolomide—brain cancer	0.000247	0.00271	CcSEcCtD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000246	0.00291	CbGpPWpGaD
Fulvestrant—Abdominal pain—Temozolomide—brain cancer	0.000246	0.00269	CcSEcCtD
Fulvestrant—Body temperature increased—Temozolomide—brain cancer	0.000246	0.00269	CcSEcCtD
Fulvestrant—Skin disorder—Etoposide—brain cancer	0.000242	0.00265	CcSEcCtD
Fulvestrant—Hyperhidrosis—Etoposide—brain cancer	0.00024	0.00263	CcSEcCtD
Fulvestrant—Anorexia—Etoposide—brain cancer	0.000237	0.0026	CcSEcCtD
Fulvestrant—Hypersensitivity—Carmustine—brain cancer	0.000237	0.0026	CcSEcCtD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000236	0.0028	CbGpPWpGaD
Fulvestrant—Nausea—Hydroxyurea—brain cancer	0.000236	0.00259	CcSEcCtD
Fulvestrant—Asthenia—Carmustine—brain cancer	0.000231	0.00253	CcSEcCtD
Fulvestrant—Hypersensitivity—Temozolomide—brain cancer	0.000229	0.00251	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000228	0.0027	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000223	0.00265	CbGpPWpGaD
Fulvestrant—Paraesthesia—Etoposide—brain cancer	0.000223	0.00245	CcSEcCtD
Fulvestrant—Asthenia—Temozolomide—brain cancer	0.000223	0.00244	CcSEcCtD
Fulvestrant—Dyspnoea—Etoposide—brain cancer	0.000222	0.00243	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000221	0.00262	CbGpPWpGaD
Fulvestrant—Diarrhoea—Carmustine—brain cancer	0.00022	0.00241	CcSEcCtD
Fulvestrant—Pruritus—Temozolomide—brain cancer	0.00022	0.00241	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—CYP2C9—brain cancer	0.000219	0.0026	CbGpPWpGaD
Fulvestrant—ESR1—FOXM1 transcription factor network—CDKN2A—brain cancer	0.000219	0.00259	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—CDK4—brain cancer	0.000218	0.00258	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—ESR2—brain cancer	0.000217	0.00257	CbGpPWpGaD
Fulvestrant—Decreased appetite—Etoposide—brain cancer	0.000216	0.00237	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Etoposide—brain cancer	0.000215	0.00235	CcSEcCtD
Fulvestrant—Fatigue—Etoposide—brain cancer	0.000214	0.00235	CcSEcCtD
Fulvestrant—Dizziness—Carmustine—brain cancer	0.000213	0.00233	CcSEcCtD
Fulvestrant—Pain—Etoposide—brain cancer	0.000213	0.00233	CcSEcCtD
Fulvestrant—Constipation—Etoposide—brain cancer	0.000213	0.00233	CcSEcCtD
Fulvestrant—Diarrhoea—Temozolomide—brain cancer	0.000213	0.00233	CcSEcCtD
Fulvestrant—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000212	0.00251	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00021	0.00249	CbGpPWpGaD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.00021	0.00249	CbGpPWpGaD
Fulvestrant—Dizziness—Temozolomide—brain cancer	0.000206	0.00225	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000205	0.00243	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—NOTCH2—brain cancer	0.000205	0.00243	CbGpPWpGaD
Fulvestrant—Vomiting—Carmustine—brain cancer	0.000204	0.00224	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Etoposide—brain cancer	0.000203	0.00223	CcSEcCtD
Fulvestrant—Rash—Carmustine—brain cancer	0.000203	0.00222	CcSEcCtD
Fulvestrant—Dermatitis—Carmustine—brain cancer	0.000203	0.00222	CcSEcCtD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000202	0.00239	CbGpPWpGaD
Fulvestrant—Headache—Carmustine—brain cancer	0.000201	0.00221	CcSEcCtD
Fulvestrant—Vomiting—Temozolomide—brain cancer	0.000198	0.00217	CcSEcCtD
Fulvestrant—Urticaria—Etoposide—brain cancer	0.000198	0.00216	CcSEcCtD
Fulvestrant—Abdominal pain—Etoposide—brain cancer	0.000197	0.00215	CcSEcCtD
Fulvestrant—Body temperature increased—Etoposide—brain cancer	0.000197	0.00215	CcSEcCtD
Fulvestrant—Rash—Temozolomide—brain cancer	0.000196	0.00215	CcSEcCtD
Fulvestrant—Dermatitis—Temozolomide—brain cancer	0.000196	0.00215	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000196	0.00232	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000195	0.00232	CbGpPWpGaD
Fulvestrant—Headache—Temozolomide—brain cancer	0.000195	0.00213	CcSEcCtD
Fulvestrant—Nausea—Carmustine—brain cancer	0.000191	0.00209	CcSEcCtD
Fulvestrant—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000188	0.00222	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—BSG—brain cancer	0.000186	0.00221	CbGpPWpGaD
Fulvestrant—ESR1—FOXM1 transcription factor network—CCND1—brain cancer	0.000185	0.00219	CbGpPWpGaD
Fulvestrant—Nausea—Temozolomide—brain cancer	0.000185	0.00202	CcSEcCtD
Fulvestrant—Hypersensitivity—Etoposide—brain cancer	0.000183	0.00201	CcSEcCtD
Fulvestrant—Asthenia—Etoposide—brain cancer	0.000178	0.00196	CcSEcCtD
Fulvestrant—Pruritus—Etoposide—brain cancer	0.000176	0.00193	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—CYP2C9—brain cancer	0.000175	0.00208	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000175	0.00207	CbGpPWpGaD
Fulvestrant—Diarrhoea—Etoposide—brain cancer	0.00017	0.00186	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000169	0.00201	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000169	0.002	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000166	0.00196	CbGpPWpGaD
Fulvestrant—Dizziness—Etoposide—brain cancer	0.000164	0.0018	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—IDH1—brain cancer	0.00016	0.0019	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000159	0.00189	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—ESR2—brain cancer	0.000158	0.00188	CbGpPWpGaD
Fulvestrant—Vomiting—Etoposide—brain cancer	0.000158	0.00173	CcSEcCtD
Fulvestrant—Rash—Etoposide—brain cancer	0.000157	0.00172	CcSEcCtD
Fulvestrant—Dermatitis—Etoposide—brain cancer	0.000157	0.00172	CcSEcCtD
Fulvestrant—Headache—Etoposide—brain cancer	0.000156	0.00171	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000152	0.00181	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—VAV1—brain cancer	0.000152	0.0018	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—NOTCH2—brain cancer	0.00015	0.00178	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.00015	0.00178	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—BSG—brain cancer	0.000149	0.00177	CbGpPWpGaD
Fulvestrant—ESR1—FOXM1 transcription factor network—MYC—brain cancer	0.000148	0.00176	CbGpPWpGaD
Fulvestrant—Nausea—Etoposide—brain cancer	0.000148	0.00162	CcSEcCtD
Fulvestrant—ESR1—LKB1 signaling events—MYC—brain cancer	0.000146	0.00172	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000145	0.00172	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000141	0.00167	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—CCND1—brain cancer	0.000141	0.00167	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00014	0.00166	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000139	0.00164	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000138	0.00163	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000136	0.00161	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000135	0.0016	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—RELA—brain cancer	0.000132	0.00157	CbGpPWpGaD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000132	0.00156	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—ERBB2—brain cancer	0.000132	0.00156	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000131	0.00155	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NOTCH2—brain cancer	0.000131	0.00155	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IL2—brain cancer	0.000129	0.00153	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—IDH1—brain cancer	0.000128	0.00152	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2C9—brain cancer	0.000128	0.00152	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000127	0.00151	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ENO2—brain cancer	0.000127	0.0015	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL2—brain cancer	0.000126	0.00149	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000126	0.00149	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.000124	0.00147	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000124	0.00146	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000123	0.00146	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000122	0.00144	CbGpPWpGaD
Fulvestrant—ESR1—LKB1 signaling events—TP53—brain cancer	0.000119	0.00142	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.000116	0.00138	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—DNMT1—brain cancer	0.000116	0.00138	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000115	0.00136	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000113	0.00134	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000112	0.00133	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000111	0.00132	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000109	0.00129	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IRS2—brain cancer	0.000109	0.00129	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—BSG—brain cancer	0.000109	0.00129	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000108	0.00128	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00127	CbGpPWpGaD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000106	0.00125	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00125	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000104	0.00124	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—ESR2—brain cancer	0.000104	0.00124	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000103	0.00123	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000103	0.00122	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ENO2—brain cancer	0.000101	0.0012	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—MYC—brain cancer	0.000101	0.00119	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—STAT3—brain cancer	0.0001	0.00119	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NOTCH2—brain cancer	9.88e-05	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—EGFR—brain cancer	9.86e-05	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	9.86e-05	0.00117	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—MYC—brain cancer	9.85e-05	0.00117	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.51e-05	0.00113	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—IDH1—brain cancer	9.37e-05	0.00111	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	8.77e-05	0.00104	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.75e-05	0.00104	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.56e-05	0.00101	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	8.52e-05	0.00101	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—DNMT1—brain cancer	8.49e-05	0.00101	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SIRT1—brain cancer	8.4e-05	0.000995	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OR4C12—brain cancer	8.19e-05	0.000971	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OR14C36—brain cancer	8.19e-05	0.000971	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—brain cancer	8.09e-05	0.000959	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.02e-05	0.000951	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.63e-05	0.000904	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ESR2—brain cancer	7.62e-05	0.000903	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—ERBB2—brain cancer	7.48e-05	0.000886	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ENO2—brain cancer	7.41e-05	0.000878	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—DNMT1—brain cancer	7.39e-05	0.000876	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH2—brain cancer	7.22e-05	0.000855	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.19e-05	0.000852	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DTX2—brain cancer	6.96e-05	0.000825	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—ESR2—brain cancer	6.95e-05	0.000824	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MYC—brain cancer	6.83e-05	0.00081	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	6.64e-05	0.000787	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	6.58e-05	0.00078	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	6.58e-05	0.000779	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH2—brain cancer	6.29e-05	0.000745	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.23e-05	0.000738	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SIRT1—brain cancer	6.14e-05	0.000727	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CG—brain cancer	5.81e-05	0.000689	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	5.79e-05	0.000686	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.5e-05	0.000652	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.45e-05	0.000646	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SIRT1—brain cancer	5.34e-05	0.000633	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	5.33e-05	0.000631	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTCH2—brain cancer	5.28e-05	0.000625	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	5.21e-05	0.000617	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—brain cancer	5.18e-05	0.000614	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HES5—brain cancer	5.11e-05	0.000606	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MYC—brain cancer	4.99e-05	0.000592	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STRADA—brain cancer	4.96e-05	0.000588	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.8e-05	0.000568	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CG—brain cancer	4.65e-05	0.000551	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.41e-05	0.000523	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	4.37e-05	0.000518	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MYC—brain cancer	4.35e-05	0.000515	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.32e-05	0.000512	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ABR—brain cancer	4.14e-05	0.000491	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLI2—brain cancer	4e-05	0.000474	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLI1—brain cancer	3.76e-05	0.000446	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT1—brain cancer	3.73e-05	0.000442	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.62e-05	0.00043	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SUFU—brain cancer	3.57e-05	0.000422	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GFAP—brain cancer	3.44e-05	0.000408	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CG—brain cancer	3.4e-05	0.000403	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ESR2—brain cancer	3.35e-05	0.000397	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—brain cancer	3.29e-05	0.00039	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HEY1—brain cancer	3.26e-05	0.000386	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DLL1—brain cancer	3.2e-05	0.000379	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH2—brain cancer	3.17e-05	0.000376	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SHH—brain cancer	2.72e-05	0.000322	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SIRT1—brain cancer	2.69e-05	0.000319	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TRPC6—brain cancer	2.62e-05	0.000311	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SMO—brain cancer	2.58e-05	0.000305	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTCH1—brain cancer	2.58e-05	0.000305	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—brain cancer	2.4e-05	0.000285	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—brain cancer	2.19e-05	0.00026	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—brain cancer	2.09e-05	0.000248	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH2—brain cancer	2.06e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VAV1—brain cancer	1.96e-05	0.000233	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2C9—brain cancer	1.83e-05	0.000217	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HES1—brain cancer	1.69e-05	0.0002	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDGFRA—brain cancer	1.61e-05	0.000191	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SPP1—brain cancer	1.56e-05	0.000185	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BSG—brain cancer	1.56e-05	0.000185	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS2—brain cancer	1.41e-05	0.000167	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—IDH1—brain cancer	1.34e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APC—brain cancer	1.25e-05	0.000148	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CG—brain cancer	1.25e-05	0.000148	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENO2—brain cancer	1.06e-05	0.000126	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—brain cancer	1.06e-05	0.000125	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RELA—brain cancer	9.75e-06	0.000115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB2—brain cancer	9.69e-06	0.000115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—brain cancer	8.78e-06	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCND1—brain cancer	8.56e-06	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CTNNB1—brain cancer	8.47e-06	0.0001	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—brain cancer	7.46e-06	8.84e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—brain cancer	7.39e-06	8.75e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—brain cancer	6.86e-06	8.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—brain cancer	6.71e-06	7.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—brain cancer	5.64e-06	6.68e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CG—brain cancer	4.86e-06	5.76e-05	CbGpPWpGaD
